NAVIN MOLECULAR Trademark

Trademark Overview


On Monday, December 21, 2020, a trademark application was filed for NAVIN MOLECULAR with the United States Patent and Trademark Office. The USPTO has given the NAVIN MOLECULAR trademark a serial number of 79308808. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by NAVIN FLUORINE INTERNATIONAL LIMITED.. The NAVIN MOLECULAR trademark is filed in the Pharmaceutical Products category with the following description:

Chemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparation...
navin molecular

General Information


Serial Number79308808
Word MarkNAVIN MOLECULAR
Filing DateMonday, December 21, 2020
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6835743
Registration DateTuesday, September 6, 2022
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, June 21, 2022

Trademark Statements


Description of MarkThe mark consists of the term "NAVIN" in stylized orange font above the term "MOLECULAR" in grey font.
Goods and ServicesChemical preparations used in the manufacture of medicinal products, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for pharmaceuticals purposes, namely, for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder chemical preparations for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for pharmaceuticals purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; medicinal and pharmaceutical preparations for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; chemical preparations for veterinary purposes for the treatment of central nervous system diseases, cancer, metabolic diseases, endocrine diseases, cardiovascular disease, immune system related diseases and disorders, infectious diseases, kidney diseases, liver diseases, gastrointestinal diseases, inflammatory diseases, oncologic disorders, skin diseases and disorders, respiratory diseases, allergic diseases, neurological disorders, pain and psychiatric disorder; disinfectants; insecticides; germicides; pesticides; preparations for fungicides, herbicides and preparations for destroying vermin
Indication of Colors claimedThe color(s) orange and grey is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"MOLECULAR"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNAVIN FLUORINE INTERNATIONAL LIMITED.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIN

Party NameNAVIN FLUORINE INTERNATIONAL LIMITED.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIN

Party NameNAVIN FLUORINE INTERNATIONAL LIMITED.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIN

Trademark Events


Event DateEvent Description
Tuesday, January 3, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 12, 2022FINAL DISPOSITION NOTICE SENT TO IB
Monday, December 12, 2022FINAL DISPOSITION PROCESSED
Tuesday, December 6, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, June 21, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 1, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 16, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 13, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 13, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 27, 2022NON-FINAL ACTION E-MAILED
Thursday, January 27, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 11, 2022PREVIOUS ALLOWANCE COUNT WITHDRAWN
Tuesday, December 21, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Thursday, December 9, 2021ASSIGNED TO LIE
Wednesday, December 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, December 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 6, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 19, 2021REFUSAL PROCESSED BY IB
Thursday, July 1, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 1, 2021REFUSAL PROCESSED BY MPU
Tuesday, June 22, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 21, 2021NON-FINAL ACTION WRITTEN
Monday, June 21, 2021ASSIGNED TO EXAMINER
Wednesday, June 16, 2021ASSIGNED TO EXAMINER
Tuesday, April 20, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 15, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB